Cargando…
Translational molecular imaging and drug development in Parkinson’s disease
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily affects elderly people and constitutes a major source of disability worldwide. Notably, the neuropathological hallmarks of PD include nigrostriatal loss and the formation of intracellular inclusion bodies containing...
Autores principales: | Haider, Ahmed, Elghazawy, Nehal H., Dawood, Alyaa, Gebhard, Catherine, Wichmann, Thomas, Sippl, Wolfgang, Hoener, Marius, Arenas, Ernest, Liang, Steven H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912681/ https://www.ncbi.nlm.nih.gov/pubmed/36759912 http://dx.doi.org/10.1186/s13024-023-00600-z |
Ejemplares similares
-
Development and Validation of [(3)H]OF-NB1 for Preclinical Assessment of GluN1/2B Candidate Drugs
por: Ahmed, Hazem, et al.
Publicado: (2022) -
Optical chemosensors for environmental monitoring of toxic metals related to Alzheimer's disease
por: El-Sewify, Islam M., et al.
Publicado: (2022) -
Synthesis and Biological Evaluation of Enantiomerically Pure (R)- and (S)-[(18)F]OF-NB1 for Imaging the GluN2B Subunit-Containing NMDA receptors
por: Korff, Marvin, et al.
Publicado: (2023) -
Editorial for Special Issue—“Early-Stage Drug Discovery: Advances and Challenges”
por: Sippl, Wolfgang
Publicado: (2023) -
Imaging Cholinergic
Receptors in the Brain by Positron
Emission Tomography
por: Zhang, Jing-Jing, et al.
Publicado: (2023)